Major Investigation · Evidence vs. Price · Regulatory & Advertising

The $100 Supplement Question

Follow the Money. Follow the Claims. Follow the Evidence.

Five widely marketed supplements. Five different promises. One question: what does the science actually support? Americans spend billions of dollars on dietary supplements, often influenced by television commercials, podcast endorsements, social media campaigns, and promises of better memory, stronger immunity, improved energy, or healthier aging. Some products cost more than $1,000 a year.

5Products examined through two independent lenses
$39–$99Monthly cost across the five, depending on plan (checked Nov. 1, 2026)
~$1,190The highest annual cost among them, at one-time monthly prices

Price is not proof

But price is not proof. Advertising is not evidence. And a clinical study showing a change in a laboratory measurement does not necessarily demonstrate that a supplement improves health.

This investigation examines five prominent products through two independent lenses:

Evidence vs. Price

What does the product cost, what benefits are promised, and what have clinical studies actually demonstrated?

Applied to: AG1 · Tru Niagen · Timeline Mitopure

Regulatory & Advertising

Have the claims been challenged by regulators? What do official enforcement records establish? Are marketing messages consistent with the available evidence?

Applied to: Prevagen · Balance of Nature

We examine the products, not the personalities selling them. We distinguish documented regulatory findings from scientific uncertainty, and we do not assume that an expensive supplement is ineffective simply because it is expensive.

Five products under the microscope

Each profile follows the same order: the promise, the central question, what the record or the research shows, and the question that remains unanswered.

Product 1 of 5

Prevagen

The memory supplement that faced a federal court

Regulatory & Advertising

Prevagen became widely known through television advertising emphasizing memory and cognitive health. Its signature ingredient is apoaequorin, a protein originally identified in jellyfish.

Can taking apoaequorin meaningfully improve human memory?

What the court record shows

The Federal Trade Commission and the New York Attorney General sued the marketer, Quincy Bioscience, in 2017. At a 2024 jury trial, jurors found that none of eight challenged statements was supported by competent and reliable scientific evidence. They found only two of the eight materially misleading, including the claim that Prevagen “reduces memory problems associated with aging.” The court then ordered the company to stop using all eight statements and later clarified that the order applies nationwide. It denied the state’s request for monetary penalties.

Quincy has appealed. The Second Circuit heard argument on February 26, 2026. We found no decision as of March 2026, the latest reporting available to us.

What consumers should know

The existence of a clinical study, or an advertisement referring to one, does not establish that a supplement produces a clinically meaningful benefit.

Investigative finding

Documented federal court action against specified advertising claims. The case is on appeal.

The unanswered question

What reliable evidence demonstrates a meaningful memory benefit from the marketed product?

Product 2 of 5

Balance of Nature

Can six capsules replace fruits and vegetables?

Regulatory & Advertising

Balance of Nature built a substantial marketing presence around concentrated fruit and vegetable supplements. Its advertising has included claims suggesting that small quantities of powdered produce provide nutritional benefits comparable to multiple servings of fruits and vegetables.

Can concentrated fruit and vegetable capsules reproduce the nutritional and health benefits of eating whole produce?

What the regulatory record shows

California, 2023. Ten county district attorneys announced a $1.1 million settlement: $250,000 in restitution for customers and $850,000 in civil penalties and investigative costs. The complaint alleged unsupported health and nutrition claims, including that a 2-gram serving of the Fruits product was the “nutritional equivalent of over 5 servings of fruits per dose,” along with automatic-renewal violations. The company did not admit liability.

Federal, 2023. A federal court in Utah entered consent decrees of permanent injunction against the product’s manufacturer and distributor and their executives. The FDA alleged unapproved-drug claims, such as claims about cancer, COVID-19, and diabetes, and manufacturing violations that made the products adulterated. A consent decree is an agreement, not a court finding. The FDA reportedly allowed the distributor to resume operations about a week later.

What consumers should know

Fruits and vegetables provide fiber, water, micronutrients, and complex food matrices. A capsule containing fruit or vegetable powder should not automatically be considered nutritionally equivalent to whole produce.

Investigative finding

Documented state and federal regulatory actions: a state settlement and federal consent decrees, not trial verdicts.

The unanswered question

What independently verified evidence supports the claimed equivalence between the capsules and recommended servings of whole fruits and vegetables?

Product 3 of 5

AG1

The premium greens powder: convenience or proven health benefit?

Evidence vs. Price

AG1 is marketed as a convenient daily nutritional supplement combining vitamins, minerals, and other ingredients in one drink. Its premium price invites a practical question: what measurable additional benefit does the formulation provide compared with a balanced diet or less expensive targeted supplementation?

Has the complete formulation demonstrated clinically meaningful health benefits in well-controlled human trials?

Individual ingredients may have established nutritional functions. That does not automatically demonstrate that combining them produces additional clinical benefits. Research should distinguish improvements in nutrient intake, blood nutrient levels, and subjective wellness reports from demonstrated reductions in disease or improvements in validated health outcomes.

What has been studied
  • Gut-health trial, 2024. A randomized, placebo-controlled trial of 30 healthy adults over four weeks. AG1 enriched some probiotic species, which the authors think came from probiotics in the product. A digestive quality-of-life difference favored AG1 but was not statistically significant (p = 0.058).
  • Nutritional-adequacy trial, 2026. A placebo-controlled crossover study of 20 young, resistance-trained adults, 14 days per arm, funded by AG1 and with AG1 employees among the authors. The product filled 2.8 more nutrient requirements than placebo, but that figure was calculated from the label’s nutrient content, not measured in blood. Overall microbiome diversity did not change.

Neither trial measured disease outcomes or validated clinical endpoints.

What consumers should know

Convenience may have value. But convenience, nutritional adequacy, and demonstrated clinical effectiveness are different things.

Investigative finding

A premium-priced formulation, studied in two small, short trials that measured nutrient intake and gut markers rather than health outcomes.

The unanswered question

Which advertised benefits are supported by randomized trials of the actual marketed formulation?

Product 4 of 5

Tru Niagen

Increasing NAD+ is not the same as reversing aging

Evidence vs. Price Trials reviewed

Tru Niagen contains nicotinamide riboside, a precursor involved in the body’s production of nicotinamide adenine dinucleotide, or NAD+. NAD+ plays important roles in cellular metabolism. Human studies have reported that nicotinamide riboside supplementation can raise NAD+ measurements.

Does increasing NAD+ translate into longer life, better physical function, or meaningful prevention of age-related disease?

A measurable change in a biological marker can establish that a supplement affects a biochemical pathway. It does not, by itself, establish that consumers will experience important health benefits.

What consumers should know

Biomarker evidence and clinical outcome evidence must be evaluated separately.

Investigative finding

The evidence for biological activity is stronger than the evidence for clinical benefit. In a small trial of 12 older men given 1 gram of nicotinamide riboside a day for 21 days, blood NAD+ more than doubled, but muscle NAD+ did not change significantly, and there was no change in mitochondrial function or grip strength. In a 32-person trial combining nicotinamide riboside with pterostilbene, muscle recovery did not improve; that trial had a company-affiliated author. We found no large, long-term trial showing that raising NAD+ with this supplement extends life or prevents age-related disease.

The unanswered question

What long-term clinical outcomes justify continued daily supplementation?

Product 5 of 5

Timeline Mitopure

The mitochondrial health promise

Evidence vs. Price

Timeline Mitopure contains urolithin A, a compound studied for its effects on mitochondrial biology and muscle function. Mitochondria play central roles in cellular energy production, and mitochondrial changes are associated with aging.

Do the observed changes produce substantial, durable improvements in physical function, particularly in older adults?

What has been studied

The best-known human trial (published in JAMA Network Open in 2022) randomized 66 adults aged 65 to 90 with low physical performance to 1,000 mg of urolithin A a day or placebo for four months.

  • Primary outcomes were not met. Six-minute walk distance rose 60.8 meters on urolithin A and 42.5 meters on placebo, a difference that was not statistically significant. Muscle energy measures also did not differ between groups.
  • A secondary result was encouraging, then faded. Muscle endurance was significantly better than placebo at two months. By four months the placebo group had caught up.
  • The authors note limits: a larger-than-expected placebo response, a small sample, no correction for multiple comparisons, and endpoints that changed after the study began. Several authors are affiliated with the product’s maker.

Evidence from relatively small or short-duration trials should not be interpreted as proof of broad rejuvenation or extended lifespan.

What consumers should know

A biologically plausible mechanism and promising early trials warrant further research, not automatic acceptance of expansive longevity claims.

Investigative finding

Emerging human evidence with important uncertainties about the size and durability of clinical benefits. The trial’s primary outcomes were not met.

The unanswered question

Are the demonstrated functional benefits sufficiently large and reproducible to justify the premium price?

Dose check: the company says each retail serving contains 500 mg of Mitopure and that its studies used 500 mg, while the 2022 trial above used 1,000 mg of urolithin A a day. The two are not the same dose, so the trial result may not transfer directly to the retail serving.

What each one costs

Annual figures assume one purchase per month at the listed price. Subscription terms matter: check how to cancel before you enroll.

ProductMonthly pricePer yearSource
Tru Niagen
300 mg, 30 capsules
$39.20 subscribed
$49.00 one-time
$470 – $588Manufacturer Confirmed
Timeline Mitopure$74 (4-month plan)
$89 (monthly plan)
$99 one-time
$888 – $1,188Manufacturer Confirmed
AG1
30 servings
$79 subscribed
$99 one-time
$948 – $1,188Verified by editor, Nov. 1, 2026 Confirmed
Balance of Nature
Fruits & Veggies
$69.99 per 28 days subscribed
$89.99 one-time
About $910 subscribed (13 shipments)Verified by editor, Nov. 1, 2026 Confirmed
Prevagen
By formulation, 30-day supply
$39.97 – $89.95$480 – $1,080Reviewed by editor, Nov. 1, 2026 Confirmed

Prices, formulations, and promotions change. Read every figure here as of the date shown on this page.

The Evidence vs. Price test

We evaluate each product using the same five questions.

  1. What does it cost?The actual price per recommended daily serving and annual cost, including subscription conditions.
  2. What is promised?The precise claims on the manufacturer’s label, website, or advertisements.
  3. What has been studied?Independent randomized trials, systematic reviews, sample sizes, duration, and clinically meaningful outcomes.
  4. What remains uncertain?Unstudied combinations, undisclosed ingredient amounts, surrogate biomarkers, long-term safety, and potential drug interactions.
  5. What is the regulatory record?FDA warning letters, FTC actions, court judgments, settlements, and other verified findings, with dates and outcomes.

A product may have credible evidence for one narrow benefit and inadequate evidence for broader marketing messages. That distinction is central to our investigation.

Where this fits in the trilogy

This investigation puts the books’ tools to work on five real products.

Book One

What the Label Doesn’t Tell You

The tools: how to weigh evidence, tell a mechanism from a result, and read a trial.

  • AG1, Tru Niagen, and Mitopure are judged with Chapters 4–6
  • Prevagen is a case study in Chapter 2’s “clinically studied”
About Book One →

Book Two

The Hollow Aisle

The regulatory gap: what the law requires anyone to prove before a product reaches your shelf.

  • Prevagen and Balance of Nature show what enforcement looks like after the fact
About Book Two →

Book Three

Prove It

The same scrutiny applied to real disease claims and real case histories.

  • Where a product’s claims meet an actual health condition
About Book Three →

Before you spend $100

A supplement label tells you what a manufacturer reports is in the bottle. It does not, by itself, establish that the product works. Ask three questions before purchasing:

  1. What specific health outcome am I trying to improve?
  2. Has this exact product, at this dose, been shown to improve that outcome?
  3. Is there a less expensive, better-supported way to achieve the same goal?

Check the label. Examine the research. Make an informed decision.

Open SuppleFactsUse Product Lookup

SuppleFacts is our free supplement research tool. Search product labels, examine ingredient amounts, explore clinical evidence, and identify potential safety concerns.

Editorial standards and disclosures

The American Supplement Investigation is an independent public-interest research project. It does not accept paid supplement sponsorships or industry advertising.

Regulatory findings are distinguished from allegations, settlements are distinguished from admissions of wrongdoing, and evidence ratings are based on the clinical question being evaluated.

Product formulations, prices, and advertising can change. Investigations should identify the product version, source, and date reviewed. Records on this page were last checked November 1, 2026.

The purpose is not to tell consumers that every supplement is worthless. It is to help them distinguish what has been demonstrated from what has merely been promised.